학술논문

FEASIBILITY AND OPTIMAL SCHEDULE OF USING ECULIZUMAB IN PATIENTS WITH HEMOLYTIC PAROXYSMAL NOCTURNAL HEMOGLOBINURIA (HPNH) WITH SEVERE APLASTIC ANEMIA (SAA) PRIOR TO HAEMOPOIETIC STEM CELL TRANSPLANT (HSCT)
Document Type
Journal
Source
BONE MARROW TRANSPLANTATION; MAR 2014, 49 pS123-pS123, 1p. Supplement: 1
Subject
Language
English
ISSN
14765365